Update on the Management of Hypophosphatasia
Overview
Authors
Affiliations
Hypophosphatasia is a rare inherited disease caused by a loss of function mutations in the gene that codes for the tissue-nonspecific alkaline phosphatase enzyme. It is autosomally inherited and at least 388 different genetic defects have been identified. The clinical presentation is variable from a severe perinatal form, that is fatal if untreated, to adult-onset disease. This review covers the pathophysiology, diagnosis and current management option including the recently licensed enzyme replacement therapy asfotase alfa.
Imamura H, Adachi T, Zhu W, Yamamoto T, Kanamura N, Onoda H Molecules. 2025; 29(24.
PMID: 39770137 PMC: 11678008. DOI: 10.3390/molecules29246049.
Diagnosis, treatment, and follow-up of patients with hypophosphatasia.
Cardenas-Aguilera J, Gonzalez-Lopez V, Zarante-Bahamon A, Prieto-Rivera J, Baquero-Rodriguez R, Chacon-Acevedo K Endocrine. 2024; 87(2):400-419.
PMID: 39663303 PMC: 11811241. DOI: 10.1007/s12020-024-04054-1.
Kinsman D, Hu J, Zhang Z, Li G Genes (Basel). 2024; 15(4).
PMID: 38674342 PMC: 11049189. DOI: 10.3390/genes15040407.
Dental manifestation and management of hypophosphatasia.
Okawa R, Nakano K Jpn Dent Sci Rev. 2022; 58:208-216.
PMID: 35814738 PMC: 9260292. DOI: 10.1016/j.jdsr.2022.06.002.
Case Report: Variations in the Gene in Chinese Patients With Hypophosphatasia.
Zhang Q, Qin Z, Yi S, Wei H, Zhou X, Shen F Front Genet. 2021; 12:732621.
PMID: 34712267 PMC: 8546181. DOI: 10.3389/fgene.2021.732621.